In contrast, our study highlights AML is a more complex disease, able to establish dynamic and redundant interactions with the BM microenvironment, with additional chemokine‐driven pathways likely balancing loss of CXCR4 signaling in parenchymal, nonmobilized AML cells (Supplementary figure 4). The gene discussed is CXCR4; the disease is acute myeloid leukemia.